Prot #0000649-02: A Phase 2b, Multi-center, Randomized, Double-blind, Placebo-controlled, Crossover Study to Evaluate Multiple Doses of ALLN-177 in Recurrent Calcium Oxalate Kidney Stone Formers with Hyperoxaluria

Project: Research project

Project Details

StatusFinished
Effective start/end date9/9/159/9/18

Funding

  • Premier Research International, LLC (Prot #0000649-02)
  • Allena Pharmaceuticals, Inc. (Prot #0000649-02)